Bloomberg Intelligence: Cohen to Run NYC Casinos (Podcast)

Bloomberg Intelligence reports several company- and sector-level developments: New York Mets owner Steve Cohen won approval to operate a casino next to Citi Field as one of three projects granted New York City gambling licenses, a regulatory win for the operator. Eli Lilly cut the price on introductory doses of its weight-loss drug Zepbound, with the lowest-dose vial priced at $299/month for cash-paying patients, a move that could pressure near-term product revenue. Airbus shares fell sharply after Reuters reported quality issues on the A320 and an emergency software update over the weekend, raising potential operational and reputational risks. BI’s 2026 telecom outlook sees adjusted U.S. wireless-service revenue growth easing to 2.3% from 2.5% in 2025, prompting a strategic push into broadband amid mounting cable competition.

Analysis

Market structure: Bally’s (BALY) being picked to operate a NYC casino is a direct positive for regional gaming — expected to reallocate a meaningful slice of NYC’s >$1bn annual gaming spend toward BALY and adjacent hospitality/retail beneficiaries (local REITs, concessions contractors). Airbus (EADSY/AIR.PA) quality headlines hit supply-side confidence for A320 operators and suppliers, pressuring European aerospace equities and boosting near-term maintenance capex for airlines; Eli Lilly’s (LLY) introductory Zepbound price cut reduces initial unit revenue but likely accelerates uptake, shifting demand growth from premium-price to volume-driven dynamics.

Risk assessment: Tail risks include NY regulatory reversals or onerous local taxes that could halve projected BALY EBITDA contribution, FAA/EASA action grounding A320 variants that could cost airlines and suppliers billions, and payer-driven GLP-1 reimbursement caps that could cut LLY obesity-drug revenue by >20% vs base. Immediate (days) risks: headline-driven volatility in BALY/EADSY/LLY; short-term (weeks–months): licensing implementation, payer guidance, FAA findings; long-term (1–3 years): structural broadband competition for telcos (VZ/T/TMUS) and durable GLP-1 market expansion.

Trade implications: Establish 2–3% long BALY position (or buy 6–9 month BALY calls ~ATM) to capture NYC license premium; enter a 1–2% short position in EADSY (or buy 3–6 month puts) to exploit continued reaction to A320 quality concerns. Pair trade: long BA vs short EADSY (1:1) as a relative-play on U.S. OEM regulatory arbitrage over 3–12 months. Reduce LLY upside exposure by 1–2% or hedge with a 3-month bear-call spread (sell ATM, buy +10% OTM) to offset downside from reimbursement moves.

Contrarian angles: Markets may underprice GLP-1 upside from lower introductory pricing—if uptake increases >30% yoy, LLY and ecosystem suppliers (healthcare services, compounding pharmacies) could see more resilient revenue in 6–12 months. Conversely, Airbus concerns may be overbaked if fixes are software-centric; avoid sizing shorts >2% until EASA/FAA detail emerges. Monitor three near-term catalysts closely: NYS licensing regs (next 30 days), EASA/FAA bulletins (7–30 days), and CMS/payer guidance on GLP-1 coverage (30–90 days).

Key Decisions for Investors

• Establish a 2–3% long position in Bally's Corporation (BALY) within 1–5 trading days; consider buying 6–9 month ATM calls to capture licensing implementation upside, trim if local tax/regulatory terms cut projected EBITDA by >25%.
• Initiate a 1–2% short position in Airbus exposure (EADSY/AIR.PA) or buy 3–6 month puts; exit or reduce if EASA/FAA statements within 30 days indicate only a software patch rather than structural hardware faults.
• Execute a pair trade: go long Boeing (BA) vs short EADSY 1:1 with 3–12 month horizon to play OEM regulatory divergence; size combined exposure to 2–3% of portfolio and use stop-loss at 12% adverse move.
• Reduce LLY exposure by 1–2% immediately and hedge remainder with a 3-month bear-call spread (sell ATM, buy +10% OTM) to protect against payer reimbursement headlines; reassess after CMS/payer guidance within 30–90 days.
• Rotate 1–2% into U.S. cable/broadband leaders (CMCSA, CHTR) over 1–3 months as telecoms push into broadband — target names with >5% free-cash-flow yield and increase if adjusted wireless-service revenue decelerates to ~2.3% in 2026 as forecast.